These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

593 related items for PubMed ID: 31213766

  • 1. SU5416 attenuated lipopolysaccharide-induced acute lung injury in mice by modulating properties of vascular endothelial cells.
    Huang X, Zhu J, Jiang Y, Xu C, Lv Q, Yu D, Shi K, Ruan Z, Wang Y.
    Drug Des Devel Ther; 2019; 13():1763-1772. PubMed ID: 31213766
    [Abstract] [Full Text] [Related]

  • 2. Hyaluronan ameliorates LPS-induced acute lung injury in mice via Toll-like receptor (TLR) 4-dependent signaling pathways.
    Xu C, Chen G, Yang W, Xu Y, Xu Y, Huang X, Liu J, Feng Y, Xu Y, Liu B.
    Int Immunopharmacol; 2015 Oct; 28(2):1050-8. PubMed ID: 26321117
    [Abstract] [Full Text] [Related]

  • 3. Ulinastatin Protects Against LPS-Induced Acute Lung Injury By Attenuating TLR4/NF-κB Pathway Activation and Reducing Inflammatory Mediators.
    Cao C, Yin C, Shou S, Wang J, Yu L, Li X, Chai Y.
    Shock; 2018 Nov; 50(5):595-605. PubMed ID: 29324628
    [Abstract] [Full Text] [Related]

  • 4. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
    Zhang X, Sun CY, Zhang YB, Guo HZ, Feng XX, Peng SZ, Yuan J, Zheng RB, Chen WP, Su ZR, Huang XD.
    J Ethnopharmacol; 2016 Jun 20; 186():91-102. PubMed ID: 27036629
    [Abstract] [Full Text] [Related]

  • 5. Knockdown of TFPI-Anchored Endothelial Cells Exacerbates Lipopolysaccharide-Induced Acute Lung Injury Via NF-κB Signaling Pathway.
    Wang BQ, Shi M, Zhang JP, Wu X, Chang MJ, Chen ZH, Shen HH, Song YL, Zhou J, Bai CX.
    Shock; 2019 Feb 20; 51(2):235-246. PubMed ID: 29438223
    [Abstract] [Full Text] [Related]

  • 6. EphA2 antagonism alleviates LPS-induced acute lung injury via Nrf2/HO-1, TLR4/MyD88 and RhoA/ROCK pathways.
    Feng G, Sun B, Liu HX, Liu QH, Zhao L, Wang TL.
    Int Immunopharmacol; 2019 Jul 20; 72():176-185. PubMed ID: 30986645
    [Abstract] [Full Text] [Related]

  • 7. USP18 mitigates lipopolysaccharide-induced oxidative stress and inflammation in human pulmonary microvascular endothelial cells through the TLR4/NF-κB/ROS signaling.
    Jiang Z, Shen J, Ding J, Yuan Y, Gao L, Yang Z, Zhao X.
    Toxicol In Vitro; 2021 Sep 20; 75():105181. PubMed ID: 33930521
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dioscin alleviates lipopolysaccharide-induced acute lung injury through suppression of TLR4 signaling pathways.
    Wang C, Li Q, Li T.
    Exp Lung Res; 2020 Sep 20; 46(1-2):11-22. PubMed ID: 31931639
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Topotecan Alleviates Lipopolysaccharide-Mediated Acute Lung Injury Via the NF-κB Signaling Pathway.
    Jin J, Xu W, Wan B, Wang X, Zhou Z, Miao Y, Lv T, Song Y.
    J Surg Res; 2019 Mar 20; 235():83-92. PubMed ID: 30691855
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Expression of IL-17A and IL-17F in lipopolysaccharide-induced acute lung injury and the counteraction of anisodamine or methylprednisolone.
    You QH, Zhang D, Niu CC, Zhu ZM, Wang N, Yue Y, Sun GY.
    Cytokine; 2014 Mar 20; 66(1):78-86. PubMed ID: 24548428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.